METHODS AND DOSAGE FORMS FOR IMPROVING THE BIOAVAILABILITY OF THERAPEUTIC AGENTS

Details for Australian Patent Application No. 2002351798 (hide)

Owner AVENTIS PHARMA DEUTSCHLAND GMBH LABOPHARM INC.

Inventors NJIKI, Laure, Patricia, Ouadji

Pub. Number AU-A-2002351798

PCT Number PCT/EP02/12062

PCT Pub. Number WO2003/037296

Priority 01125761.5 29.10.01 EP

Filing date 29 October 2002

Wipo publication date 12 May 2003

International Classifications

A61K 009/00 Medicinal preparations characterised by special physical form

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 01125761.5 29.10.01 EP

10 July 2003 Application Open to Public Inspection

  Published as AU-A-2002351798

15 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351799-METHOD FOR RECOVERING FROM AN ABNORMAL RELEASE IN A UMTS NETWORK

2002351797-BIDIRECTIONALLY PUMPED OPTICAL AMPLIFIER